Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

2013356 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov: NCT00528879.

Good health and well-being

Published in: BMC Medicine

Volume 11, Issue 1, pp. 43-43

Field-Weighted Citation Impact: 26.25